Fig. 3
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-018-5221-9/MediaObjects/12885_2018_5221_Fig3_HTML.png)
Kaplan–Meier analysis of disease-free survival. No patients with cases having overexpression of PJA2 (> third quadrant) died or had tumour recurrence during the observed period (p = 0.153)
Kaplan–Meier analysis of disease-free survival. No patients with cases having overexpression of PJA2 (> third quadrant) died or had tumour recurrence during the observed period (p = 0.153)